Screener
Organogenesis Holdings Inc. ORGO EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Organogenesis Holdings Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
FAQ
- What is Organogenesis Holdings Inc.'s EBITDA margin?
- Organogenesis Holdings Inc. (ORGO) reported EBITDA margin of -4.4% in Q2 2026.
- What is the long-term trend for Organogenesis Holdings Inc.'s EBITDA margin?
- Over 3 years (2020 to 2025), Organogenesis Holdings Inc.'s EBITDA margin has grown at a 1.0% compound annual growth rate (CAGR), from 10.3% to 10.6%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Organogenesis Holdings Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude